Health Benefits of Physical Activity Related to an Urban Riverside Regeneration.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
05 02 2019
Historique:
received: 18 12 2018
revised: 25 01 2019
accepted: 01 02 2019
entrez: 16 2 2019
pubmed: 16 2 2019
medline: 18 6 2019
Statut: epublish

Résumé

The promotion of physical activity through better urban design is one pathway by which health and well-being improvements can be achieved. This study aimed to quantify health and health-related economic impacts associated with physical activity in an urban riverside park regeneration project in Barcelona, Spain. We used data from Barcelona local authorities and meta-analysis assessing physical activity and health outcomes to develop and apply the "Blue Active Tool". We estimated park user health impacts in terms of all-cause mortality, morbidity (ischemic heart disease; ischemic stroke; type 2 diabetes; cancers of the colon and breast; and dementia), disability-adjusted life years (DALYs) and health-related economic impacts. We estimated that 5753 adult users visited the riverside park daily and performed different types of physical activity (walking for leisure or to/from work, cycling, and running). Related to the physical activity conducted on the riverside park, we estimated an annual reduction of 7.3 deaths (95% CI: 5.4; 10.2), and 6.2 cases of diseases (95% CI: 2.0; 11.6). This corresponds to 11.9 DALYs (95% CI: 3.4; 20.5) and an annual health-economic impact of 23.4 million euros (95% CI: 17.2 million; 32.8 million). The urban regeneration intervention of this riverside park provides health and health-related economic benefits to the population using the infrastructure.

Identifiants

pubmed: 30764538
pii: ijerph16030462
doi: 10.3390/ijerph16030462
pmc: PMC6388232
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet. 2016 Sep 24;388(10051):1311-24
pubmed: 27475266
Lancet. 2012 Jun 2;379(9831):2079-108
pubmed: 22651973
Environ Health Perspect. 2018 Jul 12;126(7):077003
pubmed: 30028296
Soc Sci Med. 2013 Aug;91:130-4
pubmed: 22705180
Environ Health Perspect. 2014 May;122(5):439-46
pubmed: 24584099
Int J Epidemiol. 2011 Feb;40(1):121-38
pubmed: 20630992
Prev Med. 2016 Oct;91:383-388
pubmed: 27658650
Gac Sanit. 2013 May-Jun;27(3):233-40
pubmed: 23057971
Lancet. 2017 Sep 16;390(10100):1260-1344
pubmed: 28919118
Environ Int. 2012 Nov 15;49:100-9
pubmed: 23000780
Health Place. 2015 May;33:101-8
pubmed: 25814338
Public Health. 2017 Jul;148:69-87
pubmed: 28431333
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81
pubmed: 21681120
PLoS One. 2013;8(1):e51462
pubmed: 23326315
Environ Int. 2016 Jan;86:60-7
pubmed: 26540085
Health Place. 2016 Sep;41:50-57
pubmed: 27544344
Am J Community Psychol. 2010 Dec;46(3-4):395-412
pubmed: 20941538
Appl Psychol Health Well Being. 2014 Nov;6(3):324-46
pubmed: 25044598
Prev Med. 2018 Apr;109:62-70
pubmed: 29330030
PLoS One. 2016 Mar 01;11(3):e0149990
pubmed: 26930213
J Epidemiol Community Health. 2017 Nov;71(11):1118-1121
pubmed: 28822977
Eur J Public Health. 2014 Apr;24(2):190-5
pubmed: 23531527
Prev Med. 2014 Dec;69:135-40
pubmed: 25284259
Noise Health. 2014 May-Jun;16(70):157-65
pubmed: 24953881
Int J Equity Health. 2016 Sep 15;15(1):145
pubmed: 27628650
Environ Int. 2015 Apr;77:35-41
pubmed: 25638643
J Epidemiol Community Health. 2017 Aug 7;:
pubmed: 28784629
Environ Health. 2018 Apr 16;17(1):39
pubmed: 29661194
Environ Health. 2016 Mar 08;15 Suppl 1:38
pubmed: 26960529
Psychol Med. 2009 Jan;39(1):3-11
pubmed: 18570697
Int J Environ Res Public Health. 2015 Apr 22;12(4):4354-79
pubmed: 25913182
Prev Med. 2015 Jul;76:103-14
pubmed: 25900805
BMJ Open. 2017 Jun 14;7(6):e016188
pubmed: 28615276
J Phys Act Health. 2014 Jul;11(5):977-84
pubmed: 23493147
PLoS One. 2014 Aug 18;9(8):e105471
pubmed: 25133395
Prev Med. 2013 Nov;57(5):573-9
pubmed: 23938465
Epidemiology. 2017 Jan;28(1):63-71
pubmed: 27525811
Science. 2016 May 20;352(6288):938-40
pubmed: 27199417
Cien Saude Colet. 2011 Dec;16(12):4731-44
pubmed: 22124913
Curr Environ Health Rep. 2018 Mar;5(1):77-87
pubmed: 29392643
Lancet Planet Health. 2017 Oct;1(7):e289-e297
pubmed: 29851627
PLoS One. 2017 May 9;12(5):e0177262
pubmed: 28486487
BMJ. 2016 Aug 09;354:i3857
pubmed: 27510511
N Engl J Med. 2012 Jul 26;367(4):295-7
pubmed: 22830461
Int J Hyg Environ Health. 2017 Nov;220(8):1207-1221
pubmed: 28843736
Am J Prev Med. 2015 Dec;49(6):842-9
pubmed: 26228005
Am J Epidemiol. 2011 Dec 1;174(11):1296-306
pubmed: 22079788
Health Place. 2017 May;45:77-84
pubmed: 28319857
Health Place. 2016 Mar;38:8-15
pubmed: 26796323
Aust N Z J Public Health. 1999 Jun;23(3):322-4
pubmed: 10388181

Auteurs

Cristina Vert (C)

ISGlobal (Global Health Institute Barcelona), 08003 Barcelona, Spain. cristina.vert@isglobal.org.
Department of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain. cristina.vert@isglobal.org.
CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain. cristina.vert@isglobal.org.

Mark Nieuwenhuijsen (M)

ISGlobal (Global Health Institute Barcelona), 08003 Barcelona, Spain. mark.nieuwenhuijsen@isglobal.org.
Department of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain. mark.nieuwenhuijsen@isglobal.org.
CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain. mark.nieuwenhuijsen@isglobal.org.

Mireia Gascon (M)

ISGlobal (Global Health Institute Barcelona), 08003 Barcelona, Spain. mireia.gascon@isglobal.org.
Department of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain. mireia.gascon@isglobal.org.
CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain. mireia.gascon@isglobal.org.

James Grellier (J)

European Centre for Environment and Health, University of Exeter College of Medicine and Health, Truro, Cornwall TR1 3HD, UK. J.Grellier@exeter.ac.uk.
Department of Epidemiology and Biostatistics, Imperial College, London SW7 2AZ, UK. J.Grellier@exeter.ac.uk.

Lora E Fleming (LE)

European Centre for Environment and Health, University of Exeter College of Medicine and Health, Truro, Cornwall TR1 3HD, UK. L.E.Fleming@exeter.ac.uk.

Mathew P White (MP)

European Centre for Environment and Health, University of Exeter College of Medicine and Health, Truro, Cornwall TR1 3HD, UK. Mathew.White@exeter.ac.uk.

David Rojas-Rueda (D)

ISGlobal (Global Health Institute Barcelona), 08003 Barcelona, Spain. david.rojas@isglobal.org.
Department of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain. david.rojas@isglobal.org.
CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain. david.rojas@isglobal.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH